STOK

Stoke Therapeutics, Inc. - Common Stock (STOK)

About Stoke Therapeutics, Inc. - Common Stock (STOK)

Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.

Details

Daily high

$11.79

Daily low

$11.43

Price at open

52 Week High

$16.62

52 Week Low

$5.35

Market cap

629.5M

Dividend yield

0.00%

Volume

120

Avg. volume

564,701

P/E ratio

14.66

Stoke Therapeutics, Inc. - Common Stock News